FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743262808> ?p ?o ?g. }

• W2743262808 endingPage "48" @default.
• W2743262808 startingPage "45" @default.
• W2743262808 abstract "THE AIM - to study the effect of metformin on the tubulointerstitial fibrosis development and microRNA 21 expression in urine on the model of unilateral ureteral obstruction (UUO) in rats. MATERIAL AND METHODS. Male Wistar rats weighing 230-250 g were used for modeling tubulointerstitial fibrosis following UUO. The first group (control; n = 5) rats received a standard diet, the animals of the second group (n = 5) immediately after surgery received standard diet and metformin 10 mg per day. Both groups of rats were observed for 14 days after the UUO modeling. One day before the experiment termination, in rats which were placed in a metabolic chamber urine was collected during 24 hours for subsequent miRNA 21 expression determination. After removal the animal from the experiment received samples of urine from the renal pelvis of the kidney with UUO to determine miRNA 21 expression, as well as samples of kidney tissue for subsequent histological examination. Severity of morphological changes were evaluated by quantitative morphometry to determine the relative volume of tubulointerstitium (RVTin) and relative volume of the tubular epithelium (RVTe). RESULTS. In the control group, the experimental UUO led to a logical, a statistically significant increase in RVTin compared with the contralateral kidney. Similar data were obtained by the group of animals treated with metformin. Metformin had no significant effect on the severity of RVTin neither contralateral (intact) kidney, nor kidney with UUO. UUO in animals treated with metformin resulted in a significant decrease in the value RVTe. There were no significant differences in the levels of RVTe in the intact kidneys or kidney with OOM in animals receiving and not receiving metformin. CONCLUSION. The obtained results have not confirmed nephroprotective effect of metformin on the tubulointerstitial fibrosis development in rats with UUO. However for the final resolve of this problem requires additional clinical and experimental studies." @default.
• W2743262808 created "2017-08-17" @default.
• W2743262808 creator A5000801812 @default.
• W2743262808 creator A5005503319 @default.
• W2743262808 creator A5015759871 @default.
• W2743262808 creator A5016646750 @default.
• W2743262808 creator A5016852469 @default.
• W2743262808 creator A5020897211 @default.
• W2743262808 creator A5037949631 @default.
• W2743262808 creator A5082121670 @default.
• W2743262808 date "2015-11-01" @default.
• W2743262808 modified "2023-09-25" @default.
• W2743262808 title "ВЛИЯНИЕ МЕТФОРМИНА НА ФОРМИРОВАНИЕ ТУБУЛОИНТЕРСТИЦИАЛЬНОГО ФИБРОЗА У КРЫС" @default.
• W2743262808 hasPublicationYear "2015" @default.
• W2743262808 type Work @default.
• W2743262808 sameAs 2743262808 @default.
• W2743262808 citedByCount "0" @default.
• W2743262808 crossrefType "journal-article" @default.
• W2743262808 hasAuthorship W2743262808A5000801812 @default.
• W2743262808 hasAuthorship W2743262808A5005503319 @default.
• W2743262808 hasAuthorship W2743262808A5015759871 @default.
• W2743262808 hasAuthorship W2743262808A5016646750 @default.
• W2743262808 hasAuthorship W2743262808A5016852469 @default.
• W2743262808 hasAuthorship W2743262808A5020897211 @default.
• W2743262808 hasAuthorship W2743262808A5037949631 @default.
• W2743262808 hasAuthorship W2743262808A5082121670 @default.
• W2743262808 hasConcept C126322002 @default.
• W2743262808 hasConcept C126894567 @default.
• W2743262808 hasConcept C134018914 @default.
• W2743262808 hasConcept C2777521186 @default.
• W2743262808 hasConcept C2780026642 @default.
• W2743262808 hasConcept C2780091579 @default.
• W2743262808 hasConcept C2780323712 @default.
• W2743262808 hasConcept C2780559512 @default.
• W2743262808 hasConcept C555293320 @default.
• W2743262808 hasConcept C71924100 @default.
• W2743262808 hasConcept C77411442 @default.
• W2743262808 hasConceptScore W2743262808C126322002 @default.
• W2743262808 hasConceptScore W2743262808C126894567 @default.
• W2743262808 hasConceptScore W2743262808C134018914 @default.
• W2743262808 hasConceptScore W2743262808C2777521186 @default.
• W2743262808 hasConceptScore W2743262808C2780026642 @default.
• W2743262808 hasConceptScore W2743262808C2780091579 @default.
• W2743262808 hasConceptScore W2743262808C2780323712 @default.
• W2743262808 hasConceptScore W2743262808C2780559512 @default.
• W2743262808 hasConceptScore W2743262808C555293320 @default.
• W2743262808 hasConceptScore W2743262808C71924100 @default.
• W2743262808 hasConceptScore W2743262808C77411442 @default.
• W2743262808 hasIssue "6" @default.
• W2743262808 hasLocation W27432628081 @default.
• W2743262808 hasOpenAccess W2743262808 @default.
• W2743262808 hasPrimaryLocation W27432628081 @default.
• W2743262808 hasVolume "19" @default.
• W2743262808 isParatext "false" @default.
• W2743262808 isRetracted "false" @default.
• W2743262808 magId "2743262808" @default.
• W2743262808 workType "article" @default.